← Back to Patent Explorer
US4191740A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic resin-base, antibiotic compositions containing amino acids

Assignee: Merck Patent GmbH
•
Filing: 1977-10-26
•
Granted: 1980-03-04
•
Expires: 1997-10-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract By adding amino acids to antibiotic-containing compositions having as a base polymethacrylates, acrylates or a mixture thereof, reproducible improved antibiotic-release properties are achieved.

Inventors

  • 👤 Dietrich Heusser
  • 👤 Elvira Dingeldein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 18:35
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K31/00; A61K31/70; A61L; A61L24/00; A61L24/001; A61L24/0015; A61L24/0047; A61L24/0073; A61L27/00; A61L27/40; A61L27/44; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 94 words
A pharmaceutical composition consisting essentially of a base of fine pearl polymer spheroid, particles having diameters of 1-20 mm of methyl methacrylate-methyl acrylate copolymer, at least one antibiotic selected from gentamycin, erythromycin, lincomycin, clindamycin, novobiocin, vancomycin, fusidic acid, rifamycin, polymyxins, neomycin, kanamycin and tobramycin in antimicrobial amounts of about 0.2-15% by weight and an antibiotic-liberating agent, wherein the antibiotic liberating agent consists essentially of 0.3-5% by weight of at least one aliphatic, monoamino, monocarboxylic amino acid containing up to 5 carbon atoms selected from glycine, alanine, threonine, valine, serine, hydroxyproline, proline and mixtures thereof.
Claim 2
Dependent Claim 94 words
A pharmaceutical composition consisting essentially of a base of fine pearl polymer spheroid, particles having diameters of 1-20 mm of methyl methacrylate-methyl acrylate copolymer, at least one antibiotic selected from gentamycin, erythromycin, lincomycin, clindamycin, novobiocin, vancomycin, fusidic acid, rifamycin, polymyxins, neomycin, kanamycin and tobramycin in antimicrobial amounts of about 0.2-15% by weight and an antibiotic-liberating agent, wherein the antibiotic liberating agent consists essentially of 0.3-5% by weight of at least one aliphatic, monoamino, monocarboxylic amino acid containing up to 5 carbon atoms selected from glycine, alanine, threonine, valine, serine, hydroxyproline, proline and mixtures thereof.
Claim 3
Dependent Claim 20 words
The composition of claim 1, wherein the amount of antibiotic is 0.2 to 15 weight %, based on the polymer.
Claim 4
Dependent Claim 19 words
The composition of claim 1, wherein the amino acid is glycine in a content of about 1% by weight.
Claim 5
Dependent Claim 10 words
The composition of claim 1, wherein the antibiotic is gentamycin.
Claim 6
Dependent Claim 17 words
The composition of claim 1, wherein the particles have a diameter of from 7 to 10 mm.

References Cited (Backward Citations)

US2430740A Cited
US3868447A Cited
US3955566A Cited
US4059684A Cited
US4093576A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-04 1983-09-03 1984-03-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-04 1987-09-03 1988-03-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-04 1991-09-03 1992-03-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag